Literature DB >> 2846231

Propagation and quantitation of animal herpesviruses in eight cell culture systems.

R B Peterson1, S M Goyal.   

Abstract

A comparative study was carried out to determine the relative sensitivities of eight different cell culture systems to six different herpesviruses of animals. The cells used were: OFL (ovine fetal lung), ML (mink lung), FK (ferret kidney), PTK-2 (potoroo kidney), TEK (turkey embryo kidney), ED (equine dermal), BT (bovine turbinate), and PK15 (porcine kidney). The viruses tested were: PRV (pseudorabies) of swine, CPHV (caprine herpesvirus), IBRV (infectious bovine rhinotracheitis virus), DN-599 strain of bovine herpesvirus type 4, EHV-1 (equine herpesvirus), and CHV (canine herpesvirus). On the basis of virus titers obtained and the time of appearance of CPE (cytopathic effects), ML cells were found to be the most useful because of their sensitivity to all six viruses tested. BT and OFL cells were also found to be highly sensitive to all viruses with the exception of CHV.

Entities:  

Mesh:

Year:  1988        PMID: 2846231     DOI: 10.1016/0147-9571(88)90023-9

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  12 in total

1.  Molecular and in vitro characterization of field isolates of bovine herpesvirus-1.

Authors:  Julian Ruiz-Saenz; Jairo Jaime; Gloria Ramirez; Victor Vera
Journal:  Virol Sin       Date:  2012-01-22       Impact factor: 4.327

2.  Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.

Authors:  Arthur R Frampton; Donna B Stolz; Hiroaki Uchida; William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies.

Authors:  U Werner; T Kissel
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

4.  Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.

Authors:  Gaetano Donofrio; Sandro Cavirani; Alain Vanderplasschen; Laurent Gillet; Cesidio Filippo Flammini
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

5.  Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.

Authors:  Marco Redaelli; Valentina Franceschi; Antonio Capocefalo; Domenico D'Avella; Luca Denaro; Sandro Cavirani; Carla Mucignat-Caretta; Gaetano Donofrio
Journal:  Neuro Oncol       Date:  2012-01-06       Impact factor: 12.300

6.  Bovine herpesvirus 4 infects differentiated neuronal cells in culture and establish persistent infection upon selection.

Authors:  Gaetano Donofrio; Giulio Grandi; Sandro Cavirani; Simone Taddei; Cesidio Flammini
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

7.  Replication of bovine herpesvirus type 4 in human cells in vitro.

Authors:  L Egyed
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis.

Authors:  L Gillet; F Minner; B Detry; F Farnir; L Willems; M Lambot; E Thiry; P-P Pastoret; F Schynts; A Vanderplasschen
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function.

Authors:  Gaetano Donofrio; Shan Herath; Chiara Sartori; Sandro Cavirani; Cesidio Filippo Flammini; Iain Martin Sheldon
Journal:  Reproduction       Date:  2007-07       Impact factor: 3.906

10.  Transduction of the rat brain by Bovine Herpesvirus 4.

Authors:  Marco Redaelli; Andrea Cavaggioni; Carla Mucignat-Caretta; Sandro Cavirani; Antonio Caretta; Gaetano Donofrio
Journal:  Genet Vaccines Ther       Date:  2008-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.